HIGHLIGHTS
- who: Rita B. Soares et al. from the Research Institute for Medicines (iMedULisboa), Faculty of Pharmacy, Universidade de Lisboa have published the Article: An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava, in the Journal: (JOURNAL) of 22/02/2022
- what: This study had a long duration (six months) and large sample (101 patients), thus being considered relevant in this context. In this study, anxiety was assessed by Hamilton Anxiety Rating scale (HAMA) score and decreased significantly in the kava group, compared with the placebo group. The aim of chemoprevention is to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.